KathleenMccarthy O'TooleDorrisMD

Pediatric Hematology & Oncology • Aurora, CO

Pediatric Neuro-Oncology

Associate Professor

Join to view full profile

Dr. Dorris is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dorris' full profile

Already have an account?

Office
13123 E 16th Ave
Mailstop B115
Aurora, CO 80045
Phone+1 720-777-8314

Fax+1 720-777-7289

Summary

Dr. Kathleen Dorris is a pediatric hematologist/oncologist in Aurora, CO and is affiliated with Children's Hospital Colorado. She received her medical degree from University of Virginia School of Medicine and has been in practice 13 years. She specializes in pediatric neuro-oncology.

Education & Training

Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 2008 - 2011
McGaw Medical Center of Northwestern UniversityResidency, Pediatrics, 2004 - 2007
University of Virginia School of MedicineClass of 2004
Harvard UniversityBA, 2000

Certifications & Licensure

NM State Medical License 2016 - 2027
CO State Medical License 2013 - 2025
MT State Medical License 2015 - 2025
OH State Medical License 2008 - 2014
IL State Medical License 2004 - 2008
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Pilot Study of the Effect of Trastuzumab and GM-CSF on Children With Recurrent Ependymoma Start of enrollment: 2016 Dec 01
Recruiting
Phase 1
Medical Marijuana in the Pediatric Central Nervous System Tumor Population Start of enrollment: 2016 Jan 15
Active, not recruiting
HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors Start of enrollment: 2015 Sep 01
Active, not recruiting
Phase 4
Roles: Contact
Tocilizumab in Children With ACP Start of enrollment: 2019 Sep 06
Recruiting
Early Phase 1
Roles: Contact, Principal Investigator
Phase I Study of APX005M in Pediatric CNS Tumors Start of enrollment: 2018 Mar 01
Active, not recruiting
Phase 1
Roles: Contact
MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma Start of enrollment: 2023 Apr 10
Recruiting
Phase 2
Roles: Contact
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma Start of enrollment: 2024 Jun 15
Not yet recruiting
Phase 2
Roles: Contact, Principal Investigator
A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma Start of enrollment: 2018 Aug 01
Active, not recruiting
Phase 1
Roles: Contact, Principal Investigator
ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma Start of enrollment: 2022 Dec 16
Recruiting
Phase 2
Roles: Contact
Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors Start of enrollment: 2014 May 14
Active, not recruiting
Phase 2
Roles: Principal Investigator, Contact
A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration Start of enrollment: 2020 Jan 17
Recruiting
Phase 1, Phase 2
Roles: Contact
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors Start of enrollment: 2022 Nov 21
Recruiting
Phase 1, Phase 2
Roles: Contact
Study of Ribociclib and Everolimus in HGG and DIPG Start of enrollment: 2024 Jun 28
Not yet recruiting
Phase 2
Roles: Contact
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion Start of enrollment: 2024 Sep 01
Not yet recruiting
Early Phase 1
Roles: Contact
Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPG Start of enrollment: 2017 Apr 04
Recruiting
Not Applicable
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Does pre-irradiation gross tumor volume predict the risk of progression after radiation therapy in pediatric patients with adamantinomatous craniopharyngioma?
Tamar Brooks, Dexiang Gao, Kathleen Dorris, Karlie Boone, David M Mirsky
Journal of Neurosurgery. Pediatrics. 2024-12-01
Development of Chromosome 1q+ Specific Treatment for Highest Risk Pediatric Posterior Fossa Ependymoma.
Andrea M Griesinger, Annaliese J Calzadilla, Enrique Grimaldo, Andrew M Donson, Vladimir Amani
Clinical Cancer Research. 2024-04-15
2 citations
Pediatric pineal region masses: a single-center experience over 25 years.
Noor Malik, Derek C Samples, Megan M Finneran, Sarah Graber, Kathleen Dorris
Child's Nervous System. 2023-09-01